STATEMENT SHOWING THE PRICE FIXED/REVISED BY THE
NATIONAL PHARMACEUTICAL PRICING AUTHORITY ON 17th NOVEMBER, 2009
| Item No. | Company Name/Formulation Name/Composition | Pack Size | Existing Price (Rs.) |
Revised Price (Rs.) |
%AGE Increase/Decrease |
Remarks | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
-- |
-- |
-- |
-- |
-- |
|||||||
| (i) | Non-Ceiling Packs | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| A | IMPORTED CASES | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
M/s. Pfizer Products India Pvt. Ltd. | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 1 | Depo-Medrol 80 mg (40mg/ml) | 2 ml | 77.85 | 76.16 | -2.17 | NCP | |||||
-- |
Each ml contains: | Vial | -- |
-- |
|||||||
-- |
Methyl Prednisolone Acetate – 80 mg | -- |
-- |
-- |
|||||||
-- |
Batch no. S06846 / Qty. 160056 | -- |
-- |
-- |
|||||||
-- |
Batch no. S06937/ Qty. 66396 | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 2 | Medrol 16 mg | 14’s | 149.65 | 145.54 | -2.74 | NCP | |||||
-- |
Each tablet contains: | Strip/ | -- |
-- |
|||||||
-- |
Methyl Prednisolone – 16 mg | Blister | -- |
-- |
|||||||
-- |
Batch no. L381A / Qty. 86400 Strip | -- |
-- |
-- |
-- |
||||||
-- |
Batch no. L381A / Qty. 13800 Strip | -- |
-- |
-- |
-- |
||||||
-- |
Batch no. L867B / Qty. 51632 Strip | -- |
-- |
-- |
-- |
||||||
-- |
Batch no. L868A / Qty. 52080 Strip | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 3 | Depo-Medrol 40 mg | 1 ml | 57.65 | 57.78 | 0.23 | NCP | |||||
-- |
Each vial contains: | Vial | -- |
-- |
-- |
||||||
-- |
Methyl Prednisolone Acetate – 40 mg | -- |
-- |
-- |
-- |
||||||
-- |
Batch no. S06728 / Qty. 203553 Vials | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 4 | Solu Medrol AOV 40 mg | 1 ml | 139.86 | 140.08 | 0.15 | NCP | |||||
-- |
Each vial contains: | Vial | -- |
-- |
-- |
||||||
-- |
Methyl Prednisolone Sodium Succinate – 40 mg | -- |
-- |
-- |
|||||||
-- |
Batch no. S07448 / Qty. 96218 Vials | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 5 | Solu Medrol AOV 125 mg | 2 ml | 265.94 | 266.37 | 0.16 | NCP | |||||
-- |
Each vial contains: | Vial | -- |
-- |
-- |
||||||
-- |
Methyl Prednisolone Sodium Succinate – 125 mg | -- |
-- |
-- |
|||||||
-- |
Batch no. S07454 / Qty. 73466 Vials | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
M/s. Eli Lilly and Company (India) Pvt. Ltd. | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 6 | Monocomponent Insulin | 3 ml | 470.64 | 472.90 | 0.48 | NCP | |||||
-- |
Humalog Mix 50 Pen 100 IU/mL | Disposable | -- |
-- |
-- |
||||||
-- |
Each ml contains | Pen | -- |
-- |
|||||||
-- |
50% Insulin Lispro Protamine suspension, r-DNA origin | -- |
-- |
||||||||
-- |
Batch No. A638538C / Qty. 9470 Pens | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
||||||||
| 7 | Monocomponent Insulin | 3 ml | 357.59 | 358.64 | 0.29 | NCP | |||||
-- |
Humalog Mix 50 100 IU/mL | Cartridge | -- |
-- |
|||||||
-- |
Each ml contians | -- |
-- |
-- |
|||||||
-- |
50% Insulin Lispro Protamine suspension, r-DNA origin | -- |
-- |
-- |
|||||||
-- |
Batch No. A627459J / Qty. 16530 Cartridge | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 8 | Monocomponent Insulin | 3 ml | 357.59 | 358.64 | 0.29 | NCP | |||||
-- |
Humalog Mix 25 100 IU/mL | Cartridge | -- |
-- |
|||||||
-- |
Each ml contains | -- |
-- |
-- |
|||||||
-- |
25% Insulin Lispro and 75% Insulin Lispro Protamine | -- |
-- |
-- |
-- |
||||||
-- |
suspension r-DNA origin | -- |
-- |
-- |
-- |
||||||
-- |
Batch No. A625972D / Qty. 2750 Cartridge | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
||||||||
| 9 | Monocomponent Insulin | 3 ml | 470.64 | 471.53 | 0.19 | NCP | |||||
-- |
Humalog Mix 25 Pen 100 IU/mL | Disposable | -- |
-- |
-- |
||||||
-- |
Each ml contains | Pen | -- |
-- |
-- |
||||||
-- |
25% Insulin Lispro and 75% Insulin Lispro Protamine | -- |
-- |
-- |
|||||||
-- |
suspension r-DNA origin | -- |
-- |
-- |
|||||||
-- |
Batch No. A625972G / Qty. 8865 Pens | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 10 | Monocomponent Insulin | 3ml | 357.59 | 358.64 | 0.29 | NCP | |||||
-- |
Humalog 100 IU/mL | Cartridge | -- |
-- |
-- |
||||||
-- |
Each ml contains | -- |
-- |
-- |
-- |
||||||
-- |
Insulin Lispro 100 IU | -- |
-- |
-- |
|||||||
-- |
Batch No. A613127E / Qty. 8150 Cartridge | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 11 | Monocomponent Insulin | 3ml | 470.64 | 471.53 | 0.19 | NCP | |||||
-- |
Humalog pen 100 IU/mL | Disposable | -- |
-- |
|||||||
-- |
(Insulin Lispro) | Pen | -- |
-- |
|||||||
-- |
Each ml contains | -- |
-- |
-- |
|||||||
-- |
100 IU Insulin Lispro Ph.Eur (r-DNA origin) | -- |
-- |
-- |
|||||||
-- |
Batch No. A618307A / Qty. 9900 Pens | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 12 | Monocomponent Human Insulin | 3ml | 202.97 | 203.13 | 0.08 | NCP | |||||
-- |
Huminsulin NPH 100 IU/ml | Cartridge | -- |
-- |
|||||||
-- |
Each ml contains | -- |
-- |
-- |
|||||||
-- |
100 IU Human Insulin (R-DNA origin) | -- |
-- |
-- |
|||||||
-- |
Batch No. A614617F / Qty. 24845 Cartridge | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
M/s. Novartis India Ltd. | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 13 | Vitalux Plus TR Tablet | 30’s | 266.92 | 261.30 | -2.11 | NCP | |||||
-- |
Each tablet contains: | Bottle | -- |
-- |
|||||||
-- |
Beta – Carotene (Provitamin A) – 10000 IU | -- |
-- |
-- |
|||||||
-- |
Vit. C (Ascorbic Acid) – 300 mg | -- |
-- |
-- |
|||||||
-- |
Vit. E (d-alpha tocopheryl acetate) – 100 IU | -- |
-- |
-- |
|||||||
-- |
Vit. B2 (Riboflavin)- 20 mg | -- |
-- |
-- |
|||||||
-- |
Selenium (HVP* Chelate) – 50 mcg | -- |
-- |
-- |
|||||||
-- |
Zinc (Gluconate) – 40 mg | -- |
-- |
-- |
|||||||
-- |
Copper (HVP* Chelate) – 2 mg | -- |
-- |
-- |
|||||||
-- |
Lutein (Supplying 176 mcg of Zeaxanthin) – 4 mcg | -- |
-- |
-- |
|||||||
-- |
HVP = Hydrlyzed vegetable protein | -- |
-- |
-- |
|||||||
-- |
Batch no. 1663487 / Qty. 12226 Packs | -- |
-- |
-- |
|||||||
-- |
Batch no. 1662764 / Qty. 7500 Packs | -- |
-- |
-- |
|||||||
-- |
Batch no. 1662764 / Qty. 1936 Packs | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
M/s. Novo Nordisk India Pvt. Ltd. |
|
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 14 | Novo Rapid Flex Pen | 5×3 ml | 2688.79 | 2671.82 | -0.63 | NCP | |||||
-- |
Each ml contains | Cartridge | -- |
-- |
|||||||
-- |
Soluble Insulin Aspart (monocomponent, | with Flex | -- |
-- |
|||||||
-- |
Biosynthetic Recombinant DNA origin) | Pen | -- |
-- |
|||||||
-- |
100 IU/ml in 3 ml precision delivery device | -- |
-- |
-- |
|||||||
-- |
Batch no. XP50740 / Qty. 4005 | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 15 | Novo Mix 30 FlexPen | 5×3 ml | 2688.79 | 2671.82 | -0.63 | NCP | |||||
-- |
Each ml contains: | Cartridge | -- |
-- |
|||||||
-- |
Mixture of soluble Insulin Aspart and | with Flex | -- |
-- |
|||||||
-- |
Protamine Crystallised Insulin Aspart | Pen | -- |
-- |
-- |
||||||
-- |
(Monocomponent Biosynthetic Recombinant | -- |
-- |
-- |
|||||||
-- |
DNA origin) in 100 IU/ml in 3 ml precision delivery device | -- |
-- |
||||||||
-- |
Batch no. XP50720 / Qty. 24150 | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 16 | Levemir FlexPen | 5×3 ml | 4580.24 | 4583.32 | 0.07 | NCP | |||||
-- |
Each ml contains: | Cartridge | -- |
-- |
-- |
||||||
-- |
Insulin Detemir solution for injection, | with Flex | -- |
-- |
|||||||
-- |
(Monocomponent Biosynthetic Recombinant | Pen | -- |
-- |
|||||||
-- |
DNA origin) in 100 IU/ml in 3 ml precision delivery device | -- |
-- |
||||||||
-- |
Batch no. XP50692 / Qty. 3936 | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| C | REVISION CASES | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
-- |
M/s. Reckitt Benckiser (India) Ltd. | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 17 | Dettol AntiSeptic Liquid | 12×5 ltr. | 6333.18 | 6671.84 | 5.35 | NCP | |||||
-- |
Each ml contains | HDPE | -- |
-- |
|||||||
-- |
Chloroxylenol 4.8 % w/v | Plastic Jar | -- |
-- |
|||||||
-- |
Terpineol 9.0 % v/v | (wide mouthed cap) | -- |
-- |
|||||||
-- |
Alcohol Absolute (Denatured) 13.1% v/v | -- |
-- |
-- |
|||||||
-- |
contain caramel | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 18 | Dettol AntiSeptic Liquid | 12x50ml | 110.30 | 120.80 | 9.52 | NCP | |||||
-- |
Each ml contains | Glass Bottle | -- |
-- |
|||||||
-- |
Chloroxylenol 4.8 % w/v | -- |
-- |
-- |
|||||||
-- |
Terpineol 9.0 % v/v | -- |
-- |
-- |
|||||||
-- |
Alcohol Absolute (Denatured) 13.1% v/v | -- |
-- |
-- |
|||||||
-- |
contain caramel | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 19 | Same composition at Sl. No. 18 | 12x10ml | 66.36 | 68.46 | 3.16 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 20 | Same composition at Sl. No. 18 | 12x20ml | 77.30 | 81.50 | 5.43 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 21 | Same composition at Sl. No. 18 | 12x30ml | 88.94 | 95.24 | 7.08 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 22 | Same composition at Sl. No. 18 | 12x100ml | 169.98 | 190.98 | 12.35 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 23 | Same composition at Sl. No. 18 | 12x150ml | 236.14 | 267.64 | 13.34 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 24 | Same composition at Sl. No. 18 | 12x200ml | 289.08 | 331.08 | 14.53 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 25 | Same composition at Sl. No. 18 | 12x250ml | 343.96 | 396.46 | 15.26 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 26 | Same composition at Sl. No. 18 | 12x500ml | 629.60 | 734.60 | 16.68 | NCP | |||||
-- |
-- |
Glass Bottle | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
M/s. Wockhardt Ltd. | -- |
-- |
-- |
|||||||
-- |
-- |
| -- |
-- |
|||||||
| 27 | Napsyvon Capsules | 8’s | — | 9.58 | — | NCP | |||||
-- |
Each Capsule contains | Al/PVDC | -- |
-- |
|||||||
-- |
Dextropropoxyphene Hcl 65mg | Blister Foil | -- |
-- |
|||||||
-- |
Acetaminophen 400mg | With Hologram | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 28 | CYCLO Napsyvon capsules | 8’s | — | 9.98 | — | NCP | |||||
-- |
Each Capsule contains | Al/PVDC | -- |
-- |
|||||||
-- |
Dicyclomine Hcl 10mg | Blister Foil | -- |
-- |
-- |
||||||
-- |
Dextropropoxyphene Hcl 65mg | With Hologram | -- |
-- |
|||||||
-- |
Acetaminophen 400mg | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| (ii) | Ceiling Packs | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| B | NEW CASES | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 29 | Rifampicin + Isoniazide Tablets | 6’s Al_St | — | 9.68 | — | CP | |||||
-- |
Each frilm coated tablets contains | -- |
-- |
-- |
-- |
||||||
-- |
Rifampicin 150 mg | -- |
-- |
-- |
|||||||
-- |
Isoniazide – 100 mg | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 30 | Rifampicin + Isoniazide Tablets | 6’s Al_Bl | — | 9.44 | — | CP | |||||
-- |
Each frilm coated tablets contains | -- |
-- |
-- |
-- |
||||||
-- |
Rifampicin 150 mg | -- |
-- |
-- |
|||||||
-- |
Isoniazide – 100 mg | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 31 | Rifampicin+Isoniazide+Ethambutol+ | 6’s Al_St | — | 21.90 | — | CP | |||||
-- |
Pyrazinamide Tablets | -- |
-- |
-- |
|||||||
-- |
Each frilm coated tablets contains | -- |
-- |
-- |
|||||||
-- |
Rifampicin 150 mg | -- |
-- |
-- |
-- |
||||||
-- |
Isoniazide – 100 mg | -- |
-- |
-- |
-- |
||||||
-- |
Ethambutol Hcl – 275mg | -- |
-- |
-- |
-- |
||||||
-- |
Pyrazinamide – 500mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 32 | Rifampicin+Isoniazide+Ethambutol+ | 6’s Al_Bl | — | 21.54 | — | CP | |||||
-- |
Pyrazinamide Tablets | -- |
-- |
-- |
|||||||
-- |
Each frilm coated tablets contains | -- |
-- |
-- |
|||||||
-- |
Rifampicin 150 mg | -- |
-- |
-- |
|||||||
-- |
Isoniazide – 100 mg | -- |
-- |
-- |
|||||||
-- |
Ethambutol Hcl – 275mg | -- |
-- |
-- |
|||||||
-- |
Pyrazinamide – 500mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| C | REVISION CASES | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 33 | Tablet of Ibuprofen+Paracetamol & Others | 10’s | 7.32 | 7.29 | -0.36 | CP | |||||
-- |
Each tablet contains | Strips/Blister | -- |
-- |
|||||||
-- |
Ibuprofen – 400mg | -- |
-- |
-- |
-- |
||||||
-- |
Paracetamol – 325mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 34 | Naproxen Tablets | 10’s Strips/Blister | 8.52 | 9.60 | 12.68 | CP | |||||
-- |
Each tablet contains | -- |
-- |
-- |
-- |
||||||
-- |
Naproxen – 250 mg | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 35 | Naproxen Tablets | 10’s Strips/Blister | 16.18 | 18.32 | 13.23 | CP | |||||
-- |
Each tablet contains | -- |
-- |
-- |
|||||||
-- |
Naproxen – 500 mg | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 36 | Naproxen Tablets | 10’s Strips/Blister | 25.00 | 27.62 | 10.48 | CP | |||||
-- |
Each SR/CR tablet contains | -- |
-- |
-- |
-- |
||||||
-- |
Naproxen – 750 mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 37 | Naproxen Suspension | 60 ml Plastic | 14.06 | 14.54 | 3.41 | CP | |||||
-- |
Each 5 ml contains | Bottle | -- |
-- |
-- |
||||||
-- |
Naproxen – 125 mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 38 | Same composition at Sl. No. 37 | 10 ml Plastic | 6.60 | 6.22 | -5.76 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 39 | Same composition at Sl. No. 37 | 20 ml Plastic | 8.28 | 8.00 | -3.38 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 40 | Same composition at Sl. No. 37 | 30 ml Plastic | 9.48 | 9.34 | -1.48 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 41 | Same composition at Sl. No. 37 | 50 ml Plastic | 12.40 | 12.50 | 0.81 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 42 | Same composition at Sl. No. 37 | 100 ml Plastic | 20.02 | 20.72 | 3.50 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 43 | Same composition at Sl. No. 37 | 150 ml Plastic | 27.82 | 29.00 | 4.24 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 44 | Same composition at Sl. No. 37 | 200 ml Plastic | 34.22 | 36.16 | 5.67 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 45 | Same composition at Sl. No. 37 | 250 ml Plastic | 40.76 | 43.38 | 6.43 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 46 | Same composition at Sl. No. 37 | 500 ml Plastic | 74.42 | 80.40 | 8.04 | CP | |||||
-- |
-- |
Bottle | -- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 47 | Rifampicin+Isoniazide+Ethambutol Tablets | 6’s | 15.80 | 15.16 | -4.05 | CP | |||||
-- |
Each film coated tablet contains | Al_St | -- |
-- |
|||||||
-- |
Rifampicin – 150 mg | -- |
-- |
-- |
|||||||
-- |
Isoniazide – 100 mg |  |
-- |
-- |
|||||||
-- |
Ethambutol – 275 mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 48 | Rifampicin+Isoniazide+Ethambutol Tablets | 6’s | 15.80 | 14.92 | -5.57 | CP | |||||
-- |
Each film Coated Tablet Contains: | Al_Bl | -- |
-- |
|||||||
-- |
Rifampicin – 150 mg | -- |
-- |
-- |
|||||||
-- |
Isoniazide – 100 mg | -- |
-- |
-- |
|||||||
-- |
Ethambutol – 275 mg | |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| 49 | Vitamin A Capsules | 30’s |
17.80 | 19.16 | 7.64 | CP | |||||
-- |
Each soft gelatin capsule contains | Glass Bottle | -- |
-- |
|||||||
-- |
Vitamin A (as palmitate) – 25000 IU | -- |
-- |
-- |
-- |
||||||
-- |
(eq. to Retinol 7.5 mg) in water soluble form | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 50 | Vitamin A Injection | 2.5 ml Amber | 4.24 | 4.24 | 0.00 | CP | |||||
-- |
Each ml injection contains: | Ampoules | -- |
-- |
|||||||
-- |
Vitamin A (as palmitate) – 40000 IU/ml | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 51 | Same composition at Sl. No. 50 | 1 ml Amber | — | 2.70 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 52 | Same composition at Sl. No. 50 | 2 ml Amber | — | 3.68 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 53 | Same composition at Sl. No. 50 | 3 ml Amber | — | 4.40 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 54 | Same composition at Sl. No. 50 | 4 ml Amber | — | 5.14 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 55 | Same composition at Sl. No. 50 | 5 ml Amber | — | 5.84 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 56 | Same composition at Sl. No. 50 | 10 ml Amber | — | 9.12 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 57 | Same composition at Sl. No. 50 | 15 ml Amber | — | 13.60 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 58 | Same composition at Sl. No. 50 | 20 ml Amber | — | 15.46 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 59 | Same composition at Sl. No. 50 | 25 ml Amber | — | 18.12 | — | CP | |||||
-- |
-- |
Ampoules | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
||||||||
| D | SUO-MOTU CASES | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| (i) | Suo- Moto price fixation of Doxofylline based formulations (refernce review order dated 02.07.2009) | -- |
|||||||||
-- |
-- |
-- |
-- |
||||||||
| 60 | Doxofylline Syrup | 60ml Bottle | 11.26 | 13.64 | 21.14 | CP | |||||
-- |
Each 5ml Contains | With M. Cup | -- |
-- |
|||||||
-- |
Doxofylline 100mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 61 | Same composition at Sl. No. 60 | 10ml Bottle | 6.00 | 6.40 | 6.67 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 62 | Same composition at Sl. No. 60 | 20ml Bottle | 6.86 | 7.64 | 11.37 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 63 | Same composition at Sl. No. 60 | 30ml Bottle | 7.80 | 8.98 | 15.13 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 64 | Same composition at Sl. No. 60 | 50ml Bottle | 9.48 | 11.46 | 20.89 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 65 | Same composition at Sl. No. 60 | 100ml Bottle | 14.24 | 18.22 | 27.95 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 66 | Same composition at Sl. No. 60 | 150ml Bottle | 19.56 | 25.50 | 30.37 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 67 | Same composition at Sl. No. 60 | 200ml Bottle | 23.76 | 31.68 | 33.33 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 68 | Same composition at Sl. No. 60 | 250ml Bottle | 28.12 | 38.04 | 35.28 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 69 | Same composition at Sl. No. 60 | 500ml Bottle | 50.90 | 70.72 | 38.94 | CP | |||||
-- |
-- |
With M. Cup | -- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 70 | Doxofylline Tablet | 10’s | 5.74 | 13.72 | 139.02 | CP | |||||
-- |
Each Tablet contains: | St/Bl | -- |
-- |
|||||||
-- |
Doxofylline 400mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 71 | Doxofylline Tablet | 10’s | 6.30 | 14.36 | 127.94 | CP | |||||
-- |
Each Film Coated Tablet contains: | St/Bl | -- |
-- |
|||||||
-- |
Doxofylline 400mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 72 | Doxofylline SR/CR/TR/ER Tablet | 10’s | — | 14.84 | — | CP | |||||
-- |
Each SR/CR/TR/ER Tablet contains: | St/Bl | -- |
-- |
|||||||
-- |
Doxofylline 400mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 73 | Doxofylline SR/CR/TR/ER Tablet | 10’s | — | 27.70 | — | CP | |||||
-- |
Each SR/CR/TR/ER Tablet contains: | St/Bl | -- |
-- |
|||||||
-- |
Doxofylline 800mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 74 | Doxofylline Tablet | 10’s | — | 7.64 | — | CP | |||||
-- |
Each Tablet contains: | St/Bl | -- |
-- |
|||||||
-- |
Doxofylline 200mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 75 | Doxofylline injection | 10 ml Ampule | — | 5.78 | — | CP | |||||
-- |
Each 10 ml contains: | -- |
-- |
-- |
|||||||
-- |
Doxofylline 100mg | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 76 | Same composition at Sl. No. 75 | 1 ml Ampule | — | 5.78 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 77 | Same composition at Sl. No. 75 | 2 ml Ampule | — | 2.28 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 78 | Same composition at Sl. No. 75 | 3 ml Ampule | — | 3.08 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 79 | Same composition at Sl. No. 75 | 4 ml Ampule | — | 3.56 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 80 | Same composition at Sl. No. 75 | 5 ml Ampule | — | 4.06 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 81 | Same composition at Sl. No. 75 | 15 ml Ampule | — | 6.70 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 82 | Same composition at Sl. No. 75 | 20 ml Ampule | — | 7.22 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 83 | Same composition at Sl. No. 75 | 25 ml Ampule | — | 8.64 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 84 | Doxofylline injection | 10 ml Vial | — | 7.94 | — | CP | |||||
-- |
Each 10 ml contains: | -- |
-- |
-- |
-- |
||||||
-- |
Doxofylline 100mg | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 85 | Same composition at Sl. No. 84 | 5 ml Vial | — | 6.36 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 86 | Same composition at Sl. No. 84 | 15 ml Vial | — | 8.78 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 87 | Same composition at Sl. No. 84 | 20 ml Vial | — | 10.26 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 88 | Same composition at Sl. No. 84 | 30 ml Vial | — | 11.58 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 89 | Same composition at Sl. No. 84 | 50 ml Vial | — | 14.78 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 90 | Same composition at Sl. No. 84 | 100 ml Vial | — | 22.86 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| E | Complaint cases referred by Monitoring and Enforcement Division | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 91 | Vitamin C+Kojic Acid+ | 10gm Tube | — | 6.38 | — | CP | |||||
-- |
Glycolic Acid Gel/Cream/Ointment | -- |
-- |
-- |
|||||||
-- |
Each gm contains: | -- |
-- |
-- |
|||||||
-- |
Kojic Acid Dipalmitate 2.0% w/w | -- |
-- |
-- |
-- |
||||||
-- |
Vitamin C 2.5% w/w | -- |
-- |
-- |
|||||||
-- |
Glycolic acid 10.0% w/w (as glycolic | -- |
-- |
-- |
-- |
||||||
-- |
acid solution) in a cream bases | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 92 | Same composition at Sl. No. 91 | 5gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 93 | Same composition at Sl. No. 91 | 15gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 94 | Same composition at Sl. No. 91 | 20gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 95 | Same composition at Sl. No. 91 | 25gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 96 | Same composition at Sl. No. 91 | 30gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 97 | Same composition at Sl. No. 91 | 35gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 98 | Same composition at Sl. No. 91 | 50gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 99 | Same composition at Sl. No. 91 | 75gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 100 | Same composition at Sl. No. 91 | 100gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 101 | Same composition at Sl. No. 91 | 150gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 102 | Same composition at Sl. No. 91 | 200gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 103 | Same composition at Sl. No. 91 | 250gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 104 | Same composition at Sl. No. 91 | 500gm Tube | — | 6.38 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
|||||||
| 105 | Multivitamin Tablet | 30’s | — | 41.42 | — | CP | |||||
-- |
Each Film coated tablet contains: | Bottle | -- |
-- |
|||||||
-- |
Glucosamine sulphate potassium chloride | -- |
-- |
-- |
-- |
||||||
-- |
eq. to glucosamine base 444mg. | -- |
-- |
-- |
-- |
||||||
-- |
Methyl Sulfonyl Methane (MSM) 200mg | -- |
-- |
-- |
|||||||
-- |
Vitamin C (coated) 50 mg | -- |
-- |
-- |
-- |
||||||
-- |
Vitamin D3 (coated)200 IU | -- |
-- |
-- |
|||||||
-- |
Manganese 3mg (as Manganese sulphate) | -- |
-- |
-- |
-- |
||||||
-- |
Boron 0.5 mg (as Disodium Tetraborate) | -- |
-- |
-- |
|||||||
-- |
Zinc 3mg (as Zinc sulphate Monohydrate) | -- |
-- |
-- |
-- |
||||||
-- |
Copper 0.5 mg (as copper sulphate) | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 106 | Betamethasone+Gentamycin+Tolnaftate+ | 10 gm Tube | — | 8.98 | — | CP | |||||
-- |
ICHQ+Chlorocresol Gel/Cream/Ointment | -- |
-- |
-- |
|||||||
-- |
Each gm Contains: | -- |
-- |
-- |
-- |
||||||
-- |
Betamethasone Valerate – 0.61 mg | -- |
-- |
-- |
|||||||
-- |
Gentamicin Sulphate eq. to | -- |
-- |
-- |
-- |
||||||
-- |
Gentamicin base – 1 mg | -- |
-- |
-- |
|||||||
-- |
Tolnaftate – 20 mg | -- |
-- |
-- |
-- |
||||||
-- |
ICHQ – 20 mg | -- |
-- |
-- |
|||||||
-- |
Chlorocrisol (preservative) – 1 mg | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 107 | Same composition at Sl. No. 106 | 5gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 108 | Same composition at Sl. No. 106 | 15gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 109 | Same composition at Sl. No. 106 | 20gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 110 | Same composition at Sl. No. 106 | 25gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 111 | Same composition at Sl. No. 106 | 30gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 112 | Same composition at Sl. No. 106 | 35gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 113 | Same composition at Sl. No. 106 | 50gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 114 | Same composition at Sl. No. 106 | 75gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 115 | Same composition at Sl. No. 106 | 100gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 116 | Same composition at Sl. No. 106 | 150gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 117 | Same composition at Sl. No. 106 | 200gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 118 | Same composition at Sl. No. 106 | 250gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 119 | Same composition at Sl. No. 106 | 500gm Tube | — | 8.98 | — | CP | |||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| G | Corrigendum in respect of notification no. S.O. 727(E) dated 12.03.09 for item no. 9 and 10 | -- |
|||||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
M/s. M. J. Biopharam | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
Instead of | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 120 | Insulin injection | -- |
-- |
-- |
-- |
||||||
-- |
Biphasic Isophane Ph. EUR 100 IU | -- |
-- |
-- |
|||||||
-- |
Each ml contains | -- |
-- |
-- |
|||||||
-- |
Human Insulin Ph. Eur 100 IU | -- |
-- |
-- |
-- |
||||||
-- |
(Human Insulin rDNA Origin) | -- |
-- |
-- |
-- |
||||||
-- |
M-Cresol USP – 0.25% w/v | -- |
-- |
-- |
-- |
||||||
-- |
Water for injection q.s. | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
Read as | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
Insulin injection | -- |
-- |
-- |
-- |
||||||
-- |
Soluble IP (Neutral) – 100 IU | -- |
-- |
-- |
-- |
||||||
-- |
Each ml contains | -- |
-- |
-- |
-- |
||||||
-- |
Human Insulin IP – 100 IU | -- |
-- |
-- |
-- |
||||||
-- |
(Human Insulin rDNA Origin) | -- |
-- |
-- |
|||||||
-- |
M-Cresol USP – 0.25% w/v | -- |
-- |
-- |
-- |
||||||
-- |
Water for injection q.s. | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
|||||||
-- |
Instead of | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
| 121 | Insulin injection | -- |
-- |
-- |
|||||||
-- |
Biphasic Isophane Ph. EUR 100 IU | -- |
-- |
-- |
-- |
||||||
-- |
Each ml contains | -- |
-- |
-- |
-- |
||||||
-- |
Human Insulin Ph. Eur 100 IU | -- |
-- |
-- |
|||||||
-- |
(Human Insulin rDNA Origin) | -- |
-- |
-- |
-- |
||||||
-- |
M-Cresol – 0.16% w/v | -- |
-- |
-- |
-- |
||||||
-- |
Phenol – 0.065% w/v | -- |
-- |
-- |
|||||||
-- |
Water for injection q.s. | -- |
-- |
-- |
-- |
||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
Read as | -- |
-- |
-- |
|||||||
-- |
-- |
-- |
-- |
-- |
-- |
||||||
-- |
Isophane IP – 100 IU | -- |
-- |
-- |
-- |
||||||
-- |
Each ml contians | -- |
-- |
-- |
|||||||
-- |
Human Insulin IP – 100 IU | -- |
-- |
-- |
-- |
||||||
-- |
(Human Insulin rDNA Origin) | -- |
-- |
-- |
-- |
||||||
-- |
M-Cresol – 0.16% w/v | -- |
-- |
-- |
|||||||
-- |
Phenol – 0.065% w/v | -- |
-- |
-- |
-- |
||||||
-- |
Water for injection q.s. | -- |
-- |
-- |
-- |
||||||
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)